手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 前頭葉機能評価バッテリー× | アルツハイマー病評価尺度-認知機能版× | |
|---|---|---|
| 分野 | 神経心理学 | 神経心理学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2000 | 1984 |
| 提唱者≠ | Bruno Dubois | William Rosen |
| 種類≠ | Clinician-administered neuropsychological battery for frontal lobe function | Clinician-administered cognitive scale for Alzheimer's disease |
| 原典≠ | Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621-1626. DOI ↗ | Rosen, W. G., Mohs, R. C., & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141(11), 1356-1364. DOI ↗ |
| 別名≠ | FAB, Frontal Battery | ADAS-Cog, ADAS-Cog14, ADAS-Cog13 |
| 関連 | 5 | 5 |
| 概要≠ | The Frontal Assessment Battery (FAB) is a brief, clinician-administered neuropsychological battery designed to assess frontal lobe function and executive abilities at the bedside. Developed by Dubois and colleagues at the Salpêtrière Hospital in Paris in 2000, the FAB consists of six subtests measuring conceptualization, mental flexibility, motor planning, inhibitory control, and verbal fluency. The FAB is particularly sensitive to frontotemporal dementia, Parkinson's disease with cognitive decline, and other conditions affecting prefrontal function. | The Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) is a clinician-administered cognitive assessment instrument designed specifically to measure cognitive decline in Alzheimer's disease. Developed by Rosen, Mohs, and Davis in 1984 and published in the American Journal of Psychiatry, the ADAS-Cog has become the gold standard outcome measure in pharmaceutical trials of antidementia drugs. It is sensitive to disease progression and capable of detecting cognitive change over periods as brief as 6–12 months. |
| ScholarGateデータセット ↗ |
|
|